BFS technology offers a sterile approach by eliminating human intervention in the fill & finish process, meeting the need for aseptic conditions. In terms of the amount of uncontaminated goods packaged per minute, aseptic packaging using BFS technology offers high precision. In one continuous process, BFS technology is automated using containers that are shaped, filled, and sealed. The BFS equipment is designed to eliminate the risk for external contamination, making it ideal for aseptic and sterilised drug products at a single dose (unit-dose). For aseptic packaging of infectious, ophthalmic, dental, and pre-filled syringes & injectable medications, BFS technology is commonly used. These goods do not need ventilation, so they are easy for buyers and cost-effective for retailers.

BFS technology is highly capital-intensive in the industry and the initial capital needed for a plant to be built is costly. To pack goods aseptically using BFS technology, advanced technologies and a controlled environment are required. Players with high-investment capability are entering the market and only in the long run are high returns earned. Small producers are also hesitant to invest because they do not have the funds sufficient for high initial investments.

In-house packaging demand is on the rise in the food and beverage industry. Through removing the need for warehousing of raw materials and simplifying the handling process, personalised blow fill seal technology would streamline the packaging process for businesses and will greatly increase their earnings. Blow fill seal technology is expected to be widely adopted due to its innovative leak proofing and sealing applications in the packaging of carbonated beverages.

Material Segment

Based on the material, the market is segmented into Polypropylene (PP), and Polyethylene (PE). The polypropylene material leads the market growth in 2019 and it is anticipated to hold its CAGR during the forecast years. The rise in usage of dose drug of single unit products, has provided a leading share in the polypropylene segment. A flexible, raw material, along with cost effectiveness polypropylene is highly resistant to a wide variety of chemical solutions, such as solvents and acids with a temperature range of up to 10k degree celsius. The rise of the pharmaceutical sector also offers an opportunity for the blow-fill-seal technology industry to expand due to the increase in polypropylene material use.

End Use Segment

In terms of the end use segment, the market is segmented into pharmaceutical, food & beverages, cosmetics & personal care and others. In 2019, the pharmaceutical segment accumulated the major share and is expected to continue the trend over the forecast years. In the pharmaceutical industry, the market for BFS technology is rising due to the growing use for aseptic technology with advanced materials. As this is achieved with less contamination, the BFS technology is mostly used to fill parental preparations and hence the key demand is from the pharmaceutical market. As a growing number of food and beverage suppliers have a growing demand for advanced aseptic processing technologies along with the BFS technology having a large potential demand in the global industry.

The Asia Pacific region dominated the overall market share with a CAGR of more than 7.5% in 2019 and it is projected to keep its position during the forecast years 2018-2028. The growing demand demand in Japan and China for blow-fill-seal technology, combined with the increase in the pharmaceutical sector in Asia Pacific countries. The increase in disposable incomes, the urbanized population is changing its preference to nutritious and safe prepared items. However, with the increasing demand for superior pharmaceutical packaging solutions in Asia Pacific, and its acceptance is projected to increase considerably.

North America region is forecasted to have a rising demand due to rising energy consumption in developed economies like U.S, and Canada. Pharmaceutical firms are implementing blow fill seal technologies widely in North America to promote their need for unit-dose packaging. In addition to this, the combined adoption of technology in ophthalmic and injectable products accounted for almost half the revenue share of the blow fill seal technology market in North America. As these regions house main drug manufactures, North America is expected to be a common market for blow fill seal technology. However, advanced aseptic technology is readily in consumption by the top players, which is forecasted to provide a fast growth and consumption for blow fill seal technology in the pharmaceutical industry.

The major players of the global blow-fill-seal technology market are Catalent, Unither Pharmaceuticals, Recipharm, Pharmapack, Curida, Weiler Engineering, Unipharma, The Ritedose Corporation. Moreover, the market comprises several other prominent players in the blow-fill-seal technology market as Unicep Packaging, Gerresheimer, Salvat, BioConnection, Lyondellbasell, Nupharma Group, PrimaPharma. The blow-fill-seal technology market consists of top, medium level and a number of domestic players in the global market. In addition to this, the well-established players in the industry have made various strategies and research & developments to compete with other players in the regional and global market.